Biogen MS Pill Tecfidera Gains U.S. Approval

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

March 27 (Bloomberg) -- Biogen Idec, the maker of multiple sclerosis drugs Avonex and Tysabri, won U.S. approvalfor its first pill for the disease, Tecfidera. Adam Johnson reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change